Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
WellellTPE:4106 -0.20%89 EV-to-EBITDA is 4.96 as of Aug. 31, 2026, which is 52% below its 10-year median of 10.26. GuruFocus rates TPE:4106 with a GF Score™ of 89/100 and a GF Value™ of NT$24.63 (Fairly Valued). The stock has 1 warning sign investors should review. Among 520 Medical Devices & Instruments companies, Wellell ranks better than 88.46% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Wellell's enterprise value is NT$1,743 Mil.
Wellell's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$351 Mil. Therefore, Wellell's EV-to-EBITDA for today is 4.96.
The historical rank and industry rank for Wellell's EV-to-EBITDA or its related term are showing as below:
TPE:4106'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.77 Med: 10.26 Max: 20.35
Current: 4.97
During the past 13 years, the highest EV-to-EBITDA of Wellell was 20.35. The lowest was 4.77. And the median was 10.26.
TPE:4106's EV-to-EBITDA is ranked better than 88.46% of 520
companies
in the Medical Devices & Instruments industry
Industry Median: 14.68
vs TPE:4106: 4.97
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2026-08-31), Wellell's stock price is NT$24.35.
Wellell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was NT$1.830. Therefore, Wellell's PE Ratio (TTM) for today is 13.31.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Wellell's share price for today is NT$24.35.
Wellell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.830.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Wellell's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4106 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Wellell's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wellell EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Wellell's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Wellell's EV-to-EBITDA falls into.
Wellell's current Enterprise Value is NT$1,743 Mil.
Wellell's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$351 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wellell (TPE:4106) has a EV-to-EBITDA of 4.96 as of Aug. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Wellell. This is 52% below median its historical median of 10.26. Over the past decade, Wellell's EV-to-EBITDA has ranged from 4.77 to 20.35. According to the industry distribution chart, Wellell ranks #60 out of 520 companies in the Medical Devices & Instruments industry, placing it in the top 11.5%.
Is Wellell's EV-to-EBITDA too high?
Wellell's current EV-to-EBITDA of 4.96 is 52% below median its 10-year median of 10.26. Over the past 10 years, this metric has ranged from a low of 4.77 to a high of 20.35. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.68. Wellell's value of 4.96 is 66.2% below this industry median. Based on the distribution chart, Wellell ranks #60 out of 520 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Wellell has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wellell's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Wellell ranks #60 out of 520 companies for EV-to-EBITDA. This places Wellell in the top 12% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 14.68. Wellell's value of 4.96 is 66.2% below this benchmark. Historically, Wellell's own EV-to-EBITDA has ranged from 4.77 to 20.35 over the past decade. While the company's 10-year median is 10.26 vs. the industry median of 14.68, Wellell has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.68, based on 520 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wellell's current EV-to-EBITDA of 4.96 is 66.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Wellell. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wellell's current EV-to-EBITDA is 4.96, which is 52% below median its own 10-year median of 10.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellell stock overvalued right now?
Based on GuruFocus' analysis, Wellell (TPE:4106) is currently considered Fairly Valued. The stock's GF Value™ is NT$24.63, compared to a current price of NT$24.35 — trading 1.1% below its estimated fair value. The current EV-to-EBITDA is 4.96, which is 52% below median its 10-year median of 10.26 and 66.2% below the Medical Devices & Instruments industry median of 14.68. Wellell's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Wellell (TPE:4106), the current EV-to-EBITDA is 4.96 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wellell (TPE:4106) Overvalued in 2026?
Based on GuruFocus' analysis, Wellell stock appears to be undervalued.
The current stock price of NT$24.35 is trading 1.1% below its estimated GF Value™ of NT$24.63.
GuruFocus considers Wellell to be Fairly Valued.
Key valuation signals for TPE:4106:
EV-to-EBITDA: 4.96 (52% below median its 10-year median of 10.26)
GF Value™: NT$24.63 vs. price of NT$24.35 (1.1% below fair value)
Industry Position: 66.2% below the Medical Devices & Instruments median (#60 of 520)
No single metric tells the full story. See the TPE:4106 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wellell Inc engages in the manufacturing and sale of medical supplies, import and export, as well as agency services. The company provides medical solutions for post-acute care and acute care. Its products include pressure area care, support surfaces, respiratory therapy, compression therapy, and digital health. Geographically, the company operates in Europe, America, and Asia, and the majority of its revenue is generated from Europe.
89GF Score
Get the complete analysis for TPE:4106
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4106 has been successfully added to your 
